Glioma-Derived Exosomes and Their Application as Drug Nanoparticles
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252312524 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Serena Mastantuono und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Udine, Piazzale S. Maria della Misericordia 15, 33100 Udine, Italy. Hauptthemen laut MEDLINE: Exosomes, Brain Neoplasms, Nanoparticles. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 189 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Progetto GLIOMI FVG L.R. 13-2021, PRIN tArgeting glioma invasion: an additional weapon to impRove theRapeutic Efficacy towards glioblastoma ARREST, “Progetto GLIOMI FVG L.R. 13-2021 CUP G25F21002420005”.
Abstract (Originalsprache)
Glioblastoma Multiforme (GBM) is the most aggressive primary tumor of the Central Nervous System (CNS) with a low survival rate. The malignancy of GBM is sustained by a bidirectional crosstalk between tumor cells and the Tumor Microenvironment (TME). This mechanism of intercellular communication is mediated, at least in part, by the release of exosomes. Glioma-Derived Exosomes (GDEs) work, indeed, as potent signaling particles promoting the progression of brain tumors by inducing tumor proliferation, invasion, migration, angiogenesis and resistance to chemotherapy or radiation. Given their nanoscale size, exosomes can cross the blood–brain barrier (BBB), thus becoming not only a promising biomarker to predict diagnosis and prognosis but also a therapeutic target to treat GBM. In this review, we describe the structural and functional characteristics of exosomes and their involvement in GBM development, diagnosis, prognosis and treatment. In addition, we discuss how exosomes can be modified to be used as a therapeutic target/drug delivery system for clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, University of Udine, Piazzale S. Maria della Misericordia 15, 33100 Udine, Italy.
- Department of Pathological Anatomy, University Hospital of Udine, Piazzale S. Maria della Misericordia 15, 33100 Udine, Italy.
- Institute of Clinical Pathology, University Hospital of Udine, Piazzale S. Maria della Misericordia 15, 33100 Udine, Italy.
- Department of Neurosurgery, University Hospital of Udine, Piazzale S. Maria della Misericordia 15, 33100 Udine, Italy.
ORCID-Profile: Antonio Paolo Beltrami, Daniela Cesselli
Förderung
- Progetto GLIOMI FVG L.R. 13-2021
- PRIN tArgeting glioma invasion: an additional weapon to impRove theRapeutic Efficacy towards glioblastoma ARREST
- “Progetto GLIOMI FVG L.R. 13-2021 CUP G25F21002420005”
- “PRIN tArgeting glioma invasion: an additional weapon to impRove theRapeutic Efficacy towards glioblastoma ARREST CUP G53D23003680006”
Zitieren
APA
Mastantuono, S., Manini, I., Di Loreto, C., Beltrami, A. P., Vindigni, M., & Cesselli, D. (2024). Glioma-Derived Exosomes and Their Application as Drug Nanoparticles. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252312524
Vancouver
Mastantuono S, Manini I, Di Loreto C, Beltrami AP, Vindigni M, Cesselli D. Glioma-Derived Exosomes and Their Application as Drug Nanoparticles. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252312524
BibTeX
@article{Mastantuono2024,
author = {Mastantuono, Serena and Manini, Ivana and Di Loreto, Carla and Beltrami, Antonio Paolo and Vindigni, Marco and Cesselli, Daniela},
title = {Glioma-Derived Exosomes and Their Application as Drug Nanoparticles},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252312524}
}
EUVIMED